Biotech Most Volatile: CytRx Corporation (NASDAQ:CYTR), Merrimack Pharmaceuticals (NASDAQ:MACK), CEL-SCI Corporation (NYSEMKT:CVM), IGI Laboratories (NYSEMKT:IG)

CytRx Corporation (NASDAQ:CYTR) on Mar. 5 reported financial results for the 12 months ended December 31, 2013, and also provided an overview of recent accomplishments and upcoming milestones for its clinical development programs. CytRx Corporation (NASDAQ:CYTR) stock performance was -4.14% in last session and finished the day at $5.10. Traded volume was 3,687,994 million shares in the last session and the average volume of the … Continue reading Biotech Most Volatile: CytRx Corporation (NASDAQ:CYTR), Merrimack Pharmaceuticals (NASDAQ:MACK), CEL-SCI Corporation (NYSEMKT:CVM), IGI Laboratories (NYSEMKT:IG)

Services Sector Active Stocks: Sirius XM Holdings (NASDAQ:SIRI), J.C. Penney Company (NYSE:JCP), Rite Aid Corporation (NYSE:RAD), DryShips (NASDAQ:DRYS)

SiriusXM Holdings Inc. (NASDAQ:SIRI) announced yesterday that emerging country star Cole Swindell’s exclusive concert for SiriusXM listeners at Exit/In in Nashville will air on SiriusXM’s The Highway. Sirius XM Holdings Inc. (NASDAQ:SIRI) stock performance was -1.14% in last session and finished the day at $3.47. Traded volume was 61.50 million shares in the last session and the average volume of the stock remained 50.93 million … Continue reading Services Sector Active Stocks: Sirius XM Holdings (NASDAQ:SIRI), J.C. Penney Company (NYSE:JCP), Rite Aid Corporation (NYSE:RAD), DryShips (NASDAQ:DRYS)

Zulily (NYSE:ZU) stock had its “sector perform” rating reaffirmed by research analysts at RBC Capital in a report released on Tuesday, Analyst Ratings.Net reports. They currently have a $40.00 price objective on the stock, down from their previous price objective of $50.00. RBC Capital’s price objective would indicate a potential downside of 35.05% from the stock’s previous close. Zulily Inc. (NASDAQ:ZU) stock performance was -2.72% … Continue reading Services Sector Most Volatile: Zulily Inc. (NASDAQ:ZU), AirMedia (NASDAQ:AMCN), E Commerce China Dangdang (NYSE:DANG), Inuvo (NYSEMKT:INUV)

An increase in European and U.S. sales helped Reliv International Inc. (NASDAQ:RELV) raise profits by a small amount in the fourth quarter. Reliv International, Inc (NASDAQ:RELV) stock performance was -11.60% in last session and finished the day at $2.03. Traded volume was 64,448.00million shares in the last session and the average volume of the stock remained 10.29K shares. The beta of the stock remained 1.35. … Continue reading Biotech Stocks Touching New Lows: Reliv International (NASDAQ:RELV), Can Fite Biopharma (NYSEMKT:CANF), Enzymotec (NASDAQ:ENZY), Pacific Biosciences (NASDAQ:PACB)

Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) on Mar. 3 announced the appointment of Mark P. Carthy to the company’s Board of Directors. Mr. Carthy is the Managing Partner of Orion Equity Partners, LLC, a healthcare venture capital management and advisory firm co-founded by Mr. Carthy in 2008. Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) stock performance was -5.68% in last session and finished the day at $1.25. Traded volume was … Continue reading Biotech Top Losers: Rexahn Pharmaceuticals (NYSEMKT:RNN), Aegerion Pharmaceuticals (NASDAQ:AEGR), Enzymotec Ltd (NASDAQ:ENZY), Can Fite Biopharma (NYSEMKT:CANF)

Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) was a big mover last session, as its shares rose nearly 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the trend for the healthcare company since Feb 24, as the stock is now down nearly 19%. Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) dropped -5.53 percent to $52.46 … Continue reading Biotech Top Losers: Rexahn Pharmaceuticals (NYSEMKT:RNN), Aegerion Pharmaceuticals (NASDAQ:AEGR), Enzymotec Ltd (NASDAQ:ENZY), Can Fite Biopharma (NYSEMKT:CANF)